HABA Laboratories,Inc. (TYO:4925)
1,715.00
-12.00 (-0.69%)
At close: Jan 23, 2026
HABA Laboratories,Inc. Revenue
HABA Laboratories,Inc. had revenue of 2.92B JPY in the quarter ending September 30, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to 12.16B, down -0.78% year-over-year. In the fiscal year ending March 31, 2025, HABA Laboratories,Inc. had annual revenue of 12.06B, down -2.13%.
Revenue (ttm)
12.16B
Revenue Growth
-0.78%
P/S Ratio
0.53
Revenue / Employee
21.40M
Employees
568
Market Cap
6.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.06B | -263.00M | -2.13% |
| Mar 31, 2024 | 12.32B | 286.00M | 2.38% |
| Mar 31, 2023 | 12.04B | -870.00M | -6.74% |
| Mar 31, 2022 | 12.91B | -1.40B | -9.78% |
| Mar 31, 2021 | 14.31B | -4.06B | -22.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Niitaka | 24.16B |
| SHOBIDO | 22.12B |
| Premier Anti-Aging | 15.57B |
| AXXZIA | 14.03B |
| Axas Holdings | 12.45B |
| Almado | 9.66B |
| Liberta | 9.16B |
| C'BON COSMETICS | 9.14B |